The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


AstraZeneca ABEU/1/17/1173/001-002

Main Information

Trade NameLokelma
Active SubstancesSodium zirconium cyclosilicate
Dosage FormPowder for oral suspension
Licence HolderAstraZeneca AB
Licence NumberEU/1/17/1173/001-002

Group Information

ATC CodeV03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
V03AE10 Sodium Zirconium Cyclosilicate


License statusAuthorised
Licence Issued22/03/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back